About the Rubella Session
Rubella is a contagious infection caused by a virus, which can cause fever, rash, and other symptoms. It is most commonly seen in children, but can also affect adults. The virus is spread through contact with an infected person's saliva, mucus, or droplets from their nose and throat. The most common symptom of rubella is a rash that starts on the face and then spreads over the entire body. Other common symptoms may include a mild fever, sore throat, enlarged lymph nodes in the neck, and red and watery eyes. In some cases, rubella may cause swollen joint pain, joint stiffness, or a temporary decrease in hearing. If you think you or your child may have rubella, it’s important to seek medical advice right away. Diagnosis is usually made through blood tests that detect the rubella virus, and it’s important to know if you are infected so that other family members can be monitored and vaccinated if necessary. If caught early, rubella can often be treated with rest and supportive care. Symptoms usually resolve on their own within 2-3 weeks. In pregnant women, the risk of complications is much higher. If contracted during the first three months of pregnancy, the virus can cause serious birth defects in the baby, including hearing loss, an abnormally small head, brain damage, and even miscarriage. For those who have not been vaccinated against rubella, there are several available vaccines that can help prevent the disease. It is recommended that all children and adults receive a booster dose of the vaccine at regular intervals, and particularly for those who plan to travel to countries where rubella is a risk.
Featured Speakers — Rubella 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Rubella Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IDC 2027
Why Attend the Rubella Conference 2027
Present Your Research
Oral and poster slots for original Rubella work, reviewed by the scientific committee.
Network Globally
Meet researchers, clinicians, and industry leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Rubella research and practice.
Hybrid Flexibility
Attend in person in Rome or join virtually — same program, same certificate.
Join IDC 2027 for the Rubella track
Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.
Rubella Conference 2027 — FAQs
What is the Rubella track at IDC 2027?
The Rubella track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Rubella. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Rubella sessions?
Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Rubella are all welcome — whether presenting or attending.
Can I present my research in the Rubella track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Rubella sessions?
Yes. IDC 2027 is a hybrid conference — attend the Rubella track in person in Rome or join live online, with on-demand access afterward.
Join the IDC 2027 delegation
Rome · June 21–23, 2027 · Hybrid · in-person & virtual
Attend without presenting.

